Fact Sheet  
       
 
  Overview
  Board of Directors
  Medical Advisory
  Business Advisory
> Fact Sheet
   

The Problem - Dual-Epidemics of TB and HIV/AIDS in SSA

  • 25 million HIV positive people
  • 2 million are infected with Tuberculosis (TB)
  • HIV kills 2.3 million people. Of these, TB infection is the leading cause of death.
  • Effective treatments exist, but are not reaching those who need it most

Healthspot’s Solution: Franchised network of private providers to increase access and assure quality care for TB and HIV/AIDS

  • Since 60% of health services used by the poor in Africa are private providers, Healthspot will work with these providers who are currently serving the poor
  • Since these providers offer highly variable quality of care, Healthspot will work to achieve a standardized high quality of care.

Benefits of Healthspot’s Approach

  • Close-to-client services increase access and use
  • Cost effective way to increase service delivery points for TB and HIV testing and care
  • Use existing private practitioners, thereby reducing burden on public systems
  • Improve quality and reliability of services and commodities
  • Coordinate with public sector programs

A. Healthspot Franchise International

Non-profit 501(c)(3) registered organization based in the USA . Secures funding and supports NFO.

B. Healthspot National Organization

Owned and operated by an organization with private sector mobilization experience. Responsible for ensuring quality standards, provider selection, training, data collection, marketing and branding. Will adapt international guidelines for care for a specific country.

C. National Franchise Organization

Nurses and clinical officers in full time private practice as owners. Services offered include: TB testing and treatment, HIV testing and treatment, Opportunistic Infections associated with HIV, other provider-appropriate medical care allowed under national law, ART delivery after demonstrated success within the franchise.

D. Clients

The working poor in peri-urban and rural areas with limited financial means. Current users of private providers. 

Seven Target Countries (populations over 10 million):

Phase I
    • Two years which will be used to prove the efficacy of Healthspot model
    • Kenya , Tanzania , Uganda
Phase II
    • Five years full roll out for maximal impact
    • Nigeria , Cameroon , Malawi , and Zambia
Healthspot Program Targets
Phase 1
Phase 2
Total clinics in operation
153
4,175
Clinics providing ART
6
1,323
Total Clients served
70,001
1,915,577
Total Population covered
30,427,000
82,000,000
# Clients completing TB
1,941
42,388
# Client ART and pre ARV
317
103,017
# Clients on ART
45
48,240
Cost per ART clients
$ 77,268
$ 747
Total Subsidy required
$ 7,349,485
$ 51,515,082

History

Conceptual development supported by Rockefeller and StopTb of WHO. Medical and business advisory groups to Healthspot facilitated development of business and financial plans. Large consultative conference in Nairobi (Jun ’04) finalized model. Pilot for TB franchise in progress in Kibera slums in Kenya. Goal to launch initiative in early 2005.

Points of Contact

Dr. Dominic Montagu – Email: dmontagu@healthspotfranchise.org - +1 (415) 597-8214
Dr. Gijs Elzinga – Email: gelzinga@healthspotfranchise.org - +31 (30) 274 2345

 
       
       
       

74 New Montgomery, Suite 508, San Francisco, California 94105-3411, USA
Tel: +1.415.597.9326 Fax: +1.415.597.8299 Email: info@healthspotfranchise.org